Linda F. Powers J.D.
Net Worth

Last updated:

What is Linda F. Powers J.D. net worth?

The estimated net worth of Ms. Linda F. Powers J.D. is at least $23,236,221 as of 28 Dec 2018. She owns shares worth $7,147,058 as insider, has earned $2,089,163 from insider trading and has received compensation worth at least $14,000,000 in Northwest Biotherapeutics, Inc..

What is the salary of Linda F. Powers J.D.?

Ms. Linda F. Powers J.D. salary is $700,000 per year as Chairperson, Chief Executive Officer, Pres, Chief Financial Officer & Chief Accounting Officer in Northwest Biotherapeutics, Inc..

How old is Linda F. Powers J.D.?

Ms. Linda F. Powers J.D. is 69 years old, born in 1956.

What stocks does Linda F. Powers J.D. currently own?

As insider, Ms. Linda F. Powers J.D. owns shares in one company:

Company Title Shares Price per share Total value
Northwest Biotherapeutics, Inc. (NWBO) Chairperson, Chief Executive Officer, Pres, Chief Financial Officer & Chief Accounting Officer 29,411,760 $0.24 $7,147,058

What does Northwest Biotherapeutics, Inc. do?

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

NWBO logo
NWBO
Northwest Biotherapeutics, Inc.
$0.24

Linda F. Powers J.D. insider trading

Northwest Biotherapeutics, Inc.

Ms. Linda F. Powers J.D. has made 14 insider trades between 2005-2018, according to the Form 4 filled with the SEC. Most recently she sold 804,146 units of NWBO stock worth $136,705 on 28 Dec 2018.

The largest trade she's ever made was exercising 6,468,153 units of NWBO stock on 12 Dec 2012. As of 28 Dec 2018 she still owns at least 29,411,760 units of NWBO stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Restricted Common Stock, par value $0.001 804,146 $0.17 $136,705
Sale
Restricted Common Stock, par value $0.001 3,558,639 $0.17 $604,969
Sale
Class D-2 Warrants 1,779,320 N/A N/A
Purchase
Warrants 3,234,078 $6.4 $20,698,099
Purchase
Common Stock 6,468,153 N/A N/A
Sale
Common Stock 866,667 $0.75 $650,000
Sale
Common Stock 40,048 $0.87 $34,842
Sale
Common Stock 7,000 $0.91 $6,370
Sale
Common Stock 200,000 $0.9 $180,000
Sale
Common Stock 233,552 $0.93 $217,203
Sale
Common Stock 20,000 $0.82 $16,400
Sale
Common Stock 79,000 $0.93 $73,470
Sale
Common Stock 30,000 $0.89 $26,700
Sale
Common Stock 32,500 $0.97 $31,525
Sale
Common Stock 7,900 $1.01 $7,979
Sale
Common Stock 100,000 $1.03 $103,000
Purchase
Warrant 4,000,000 N/A N/A

Northwest Biotherapeutics key executives

Northwest Biotherapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Marnix L. Bosch M.B.A., Ph.D., MBA (66) Chief Technical Officer
  • Mr. Leslie J. Goldman (80) Senior Vice President & Gen. Counsel
  • Ms. Linda F. Powers J.D. (69) Chairperson, Chief Executive Officer, Pres, Chief Financial Officer & Chief Accounting Officer